Carl Elkin

Title: Carl Elkin: Innovator in Protein Interaction Inhibitors

Introduction

Carl Elkin is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biochemistry, particularly in the design of inhibitors that target protein-processivity factor interactions. With a total of 2 patents, his work has implications for the treatment of various diseases.

Latest Patents

Elkin's latest patents include a method for the structure-based identification and selection of inhibitors of processivity factor binding to proteins. This invention provides a detailed characterization of the protein/processivity factor interface and outlines methods for inhibiting this binding. One embodiment of the invention features a class of peptidomimetics that mimic helical portions of proteins. Additionally, he has developed a patent related to the oligomerization of hepatitis delta antigen, which encompasses HDAg peptides, including mutants and derivatives. This invention also covers methods for multivalent expression and the use of these molecules in various applications.

Career Highlights

Carl Elkin is affiliated with Harvard College, where he continues to advance research in his field. His innovative approaches have garnered attention and recognition within the scientific community.

Collaborations

Elkin has collaborated with esteemed colleagues such as James Hogle and Harmon J Zuccola, contributing to the advancement of research in protein interactions.

Conclusion

Carl Elkin's work exemplifies the intersection of innovation and practical application in biochemistry. His patents not only enhance our understanding of protein interactions but also pave the way for potential therapeutic advancements.